Crossmark

Fabrication of chitosan-coated selenium nanoparticles improved anti-inflammation in the treatment of spinal cord injury by reduced ROS and mitochondrial potential

Crossref DOI link: https://doi.org/10.1007/s10853-025-10803-y

Published Online: 2025-05-02

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Zhaofei

Liu, Xiangfei

He, Guoyun

Xu, Xiang

Wang, Yansong https://orcid.org/0009-0004-7395-7441
Funding

Funding for this research was provided by:

Shanghai Baoshan Science and Technology Commission (BSWSYC-2023-15, 2023-E-27, 2024-E-68)

UMCARE Research Fund (UM0224004)

Baoshan District Health Commission Key Subject Construction Project (BSZK-2023- A07)
License Information

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-05-01
More Information

Article History

Received: 3 November 2024

Accepted: 11 March 2025

First Online: 2 May 2025

Declarations

:

: The authors declare that they have no competing interests.

: All animal experiments were approved by the Animal Care and Experiment Committee at the Department of Orthopedic Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, 150001, PR China.

: Not applicable.

Document is current

Any future updates will be listed below